MY194834A - Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers - Google Patents

Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers

Info

Publication number
MY194834A
MY194834A MYPI2019005925A MYPI2019005925A MY194834A MY 194834 A MY194834 A MY 194834A MY PI2019005925 A MYPI2019005925 A MY PI2019005925A MY PI2019005925 A MYPI2019005925 A MY PI2019005925A MY 194834 A MY194834 A MY 194834A
Authority
MY
Malaysia
Prior art keywords
peptides
combination
rcc
scaffolds
cancers
Prior art date
Application number
MYPI2019005925A
Inventor
Colette Song
Oliver Schoor
Jens Fritsche
Andrea Mahr
Toni Weinschenk
Harpreet Singh
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority to MYPI2019005925A priority Critical patent/MY194834A/en
Publication of MY194834A publication Critical patent/MY194834A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
MYPI2019005925A 2017-08-27 2017-08-27 Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers MY194834A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2019005925A MY194834A (en) 2017-08-27 2017-08-27 Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2019005925A MY194834A (en) 2017-08-27 2017-08-27 Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers

Publications (1)

Publication Number Publication Date
MY194834A true MY194834A (en) 2022-12-19

Family

ID=87569351

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019005925A MY194834A (en) 2017-08-27 2017-08-27 Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers

Country Status (1)

Country Link
MY (1) MY194834A (en)

Similar Documents

Publication Publication Date Title
MX2022000219A (en) Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (rcc) and other cancers.
PH12018500551A1 (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018500864A1 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
MX2018004140A (en) Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers.
MX2018009958A (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers.
MX2018005273A (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers.
MX2017014008A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers.
PH12019502308A1 (en) Peptides and combination thereof for use in the immunotherapy against cancers
MX2018011220A (en) Peptides and combination of peptides for use in immunotherapy against cancers.
PH12019502300A1 (en) Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers
MY196837A (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018500665A1 (en) Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
PH12017501994A1 (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
PH12017502234A1 (en) Novel cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
PH12018502108A1 (en) Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
PH12018501639A1 (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
MY194834A (en) Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers
MY196687A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196395A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof For use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196399A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196396A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196688A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
MY197511A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers